Viking Therapeutics 'cov khoom lag luam tawm tom qab Madrigal qhia cov ntaub ntawv zoo txog nws cov tshuaj siab

Shares ntawm Viking Therapeutics Inc.
VKTX,
+ 77.61%
dhia 55% hauv kev ua lag luam ua ntej hnub Monday tom qab lub tuam txhab uas tseem tab tom txhim kho cov thyroid hormone receptor beta agonist raws li kev kho mob rau cov tsis muaj cawv steatohepatitis (NASH) thiab fibrosis tshaj tawm cov ntaub ntawv zoo, cov ntaub ntawv lig. Madrigal Pharmaceuticals Inc.
MDGL,
+ 234.03%
tau hais rau hnub Monday nws yog lub hom phiaj kom tau txais kev pom zoo nrawm hauv Asmeskas rau nws cov tshuaj. Viking tus neeg sib tw kho mob tam sim no nyob rau theem 2b kev sim tshuaj. Lub tuam txhab cov khoom lag luam poob qis 24.7% txog rau xyoo no, thaum lub dav S&P 500
SPX,
-0.61%
tau poob 19.1%.